Nanotargeted Delivery of Immune Therapeutics in Type 1 Diabetes.
Jung S, Ben Nasr M, Bahmani B, Usuelli V, Zhao J, Sabiu G, Seelam AJ, Naini SM, Balasubramanian HB, Park Y, Li X, Khalefa SA, Kasinath V, Williams MD, Rachid O, Haik Y, Tsokos GC, Wasserfall CH, Atkinson MA, Bromberg JS, Tao W, Fiorina P, Abdi R.
Jung S, et al. Among authors: bromberg js.
Adv Mater. 2023 Oct;35(40):e2300812. doi: 10.1002/adma.202300812. Epub 2023 Aug 16.
Adv Mater. 2023.
PMID: 37357903
Free PMC article.